Today

Agents

Chat

Arena

Discover

More

App

Tonix names CEO Seth Lederman interim chief medical officer - TNXP News | Rallies

Tonix names CEO Seth Lederman interim chief medical officer

TNXP•2026-08-18

Tonix appoints Lederman as interim chief medical officer

Tonix Pharmaceuticals appointed Seth Lederman as interim chief medical officer, effective Aug. 18, 2026.
Lederman has served as president, chief executive officer, and chairman since October 2011.
No appointment arrangements or understandings were disclosed with other parties.

Related News

Liberty Latin America 10% owner John C. Malone acquires 6,761 common shares worth $57,468.5

LILA•2026-08-18

Inneova Holdings announces annual general meeting

INEO•2026-08-18

Booking director Vanessa Ames Wittman sells 375 shares for $79,125

Sources

S

Tonix names CEO Seth Lederman interim chief medical officer

Sec

2026-08-18

OpenAI Says Paused Frontier Model Inference In Research Clusters After Hugging Face Incident

MSFT•2026-08-18

Mitesco halts Series A preferred stock redemptions in capital structure overhaul

MITI•2026-08-18